Teva Pharmaceutical Industries Ltd (TEVJF) Total Liabilities (2009 - 2026)
Teva Pharmaceutical Industries' (TEVJF) quarterly Total Liabilities came in at $32.1 billion in Q2 2026, down 3.59% YoY from $33.3 billion in Q2 2025, and up 0.91% on a QoQ basis from $31.8 billion in Q1 2026.
Teva Pharmaceutical Industries Ltd (TEVJF) Total Liabilities (2009 - 2026) Analysis & Trends
Teva Pharmaceutical Industries (TEVJF) has 18 years of Total Liabilities data on file, last reported at $32.1 billion in Q2 2026.
- Quarterly Total Liabilities fell 3.59% year-over-year to $32.1 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $32.1 billion (down 3.59% YoY) and the FY2025 annual result came in at $32.8 billion, down 2.3% from the prior year.
- Total Liabilities rose to $32.1 billion in Q2 2026, from $31.8 billion in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $36.8 billion in Q1 2022 to a low of $31.8 billion in Q1 2026.
- A 5-year average of $34.3 billion and a median of $34.8 billion in 2022 frame the typical range for Total Liabilities.
- Annual changes were most pronounced in 2024 — Total Liabilities gained 1.92% — and 2025, when it fell 8.75%.
- Tracing TEVJF's Total Liabilities over 5 years: stood at $35.4 billion in 2022, then fell by 0.17% to $35.4 billion in 2023, then declined by 4.94% to $33.6 billion in 2024, then decreased by 2.3% to $32.8 billion in 2025, then retreated by 2.24% to $32.1 billion in 2026.
- The last three Total Liabilities figures came in at $32.1 billion (Q2 2026), $31.8 billion (Q1 2026), and $32.8 billion (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 32.10 Bn |
| Mar 31, 2026 | 31.81 Bn |
| Dec 31, 2025 | 32.83 Bn |
| Sep 30, 2025 | 32.60 Bn |
| Jun 30, 2025 | 33.30 Bn |
| Mar 31, 2025 | 32.15 Bn |
| Dec 31, 2024 | 33.61 Bn |
| Sep 30, 2024 | 35.38 Bn |
| Jun 30, 2024 | 34.77 Bn |
| Mar 31, 2024 | 35.23 Bn |
| Dec 31, 2023 | 35.35 Bn |
| Sep 30, 2023 | 34.71 Bn |
| Jun 30, 2023 | 35.51 Bn |
| Mar 31, 2023 | 34.96 Bn |
| Dec 31, 2022 | 35.41 Bn |
| Sep 30, 2022 | 34.75 Bn |
| Jun 30, 2022 | 36.12 Bn |
| Mar 31, 2022 | 36.80 Bn |
| Dec 31, 2021 | 36.42 Bn |
| Sep 30, 2021 | 36.40 Bn |